Skip to main content
Jess Kerr-Gaffney

Dr Jess Kerr-Gaffney

Research Associate

Research

WhatsApp Image 2024-04-25 at 3.23.03 PM (1)
Psychoactive Trials Group

Psychoactive Trials Group

News

Quetiapine augmentation found to be more clinically and cost-effective for treatment-resistant depression compared to lithium

New research has found that quetiapine augmentation – a treatment for depression in people that have't fully responded to antidepressants – is both more...

Packet of pills

Research

WhatsApp Image 2024-04-25 at 3.23.03 PM (1)
Psychoactive Trials Group

Psychoactive Trials Group

News

Quetiapine augmentation found to be more clinically and cost-effective for treatment-resistant depression compared to lithium

New research has found that quetiapine augmentation – a treatment for depression in people that have't fully responded to antidepressants – is both more...

Packet of pills